Growth Metrics

Nuwellis (NUWE) Preferred Stock Liabilities (2016 - 2026)

Nuwellis posted quarterly Preferred Stock Liabilities of $8000.0 for Q1 2026, up 100.0% year-on-year from $4000.0 in Q1 2025, and up 33.33% on a QoQ basis from $6000.0 in Q4 2025.

Nuwellis (NUWE) has 5 years of Preferred Stock Liabilities data on file, last reported at $8000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Preferred Stock Liabilities rose 100.0% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $8000.0 (up 100.0% YoY), and the FY2025 full-year result was $6000.0, up 200.0% from the prior year.
  • Preferred Stock Liabilities for Q1 2026 stood at $8000.0, up from $6000.0 in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $221000.0 in Q4 2023 and bottomed at $2000.0 in Q1 2024.
  • The 4-year median for Preferred Stock Liabilities is $4500.0 (2025), against an average of $25800.0.
  • The widest annual swing landed in 2024, when Preferred Stock Liabilities plunged 99.1%; it then surged 200.0% in 2025.
  • A 4-year view of Preferred Stock Liabilities shows it stood at $221000.0 in 2023, then slumped by 99.1% to $2000.0 in 2024, then soared by 200.0% to $6000.0 in 2025, then surged by 33.33% to $8000.0 in 2026.
  • The last three Preferred Stock Liabilities figures came in at $8000.0 (Q1 2026), $6000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn 8,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8,000.00
Dec 31, 2025 6,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 221,000.00
Dec 31, 2016 485,000.00